nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—FDPS—prostate gland—prostate cancer	0.0121	0.224	CbGeAlD
Pamidronate—FDPS—seminal vesicle—prostate cancer	0.0102	0.189	CbGeAlD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—MBTPS1—prostate cancer	0.00976	0.0779	CbGpPWpGaD
Pamidronate—FDPS—renal system—prostate cancer	0.00826	0.152	CbGeAlD
Pamidronate—FDPS—urethra—prostate cancer	0.00811	0.15	CbGeAlD
Pamidronate—FDPS—SREBP signalling—MBTPS1—prostate cancer	0.0079	0.0631	CbGpPWpGaD
Pamidronate—FDPS—bone marrow—prostate cancer	0.00624	0.115	CbGeAlD
Pamidronate—FDPS—testis—prostate cancer	0.00534	0.0985	CbGeAlD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—NCOA2—prostate cancer	0.00444	0.0354	CbGpPWpGaD
Pamidronate—FDPS—lymph node—prostate cancer	0.00387	0.0714	CbGeAlD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—NCOA1—prostate cancer	0.00374	0.0299	CbGpPWpGaD
Pamidronate—Histamine Phosphate—SLC22A3—prostate cancer	0.00372	0.369	CrCbGaD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—RXRA—prostate cancer	0.00356	0.0284	CbGpPWpGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA2—prostate cancer	0.00355	0.0283	CbGpPWpGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA1—prostate cancer	0.00299	0.0239	CbGpPWpGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—RXRA—prostate cancer	0.00284	0.0227	CbGpPWpGaD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—PPARA—prostate cancer	0.00272	0.0217	CbGpPWpGaD
Pamidronate—Histamine Phosphate—SLC22A1—prostate cancer	0.00267	0.265	CrCbGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—prostate cancer	0.00217	0.0173	CbGpPWpGaD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—CREBBP—prostate cancer	0.00216	0.0172	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—SIRT1—prostate cancer	0.00211	0.0169	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—LPL—prostate cancer	0.00199	0.0159	CbGpPWpGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CREBBP—prostate cancer	0.00172	0.0138	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.00167	0.0133	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	0.00167	0.0133	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	0.00146	0.0117	CbGpPWpGaD
Pamidronate—Risedronate—PTGS2—prostate cancer	0.00146	0.145	CrCbGaD
Pamidronate—FDPS—SREBP signalling—INS—prostate cancer	0.00143	0.0114	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	0.00139	0.0111	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	0.00139	0.0111	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	0.00139	0.0111	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.00132	0.0106	CbGpPWpGaD
Pamidronate—Clodronate—PTGS2—prostate cancer	0.0013	0.129	CrCbGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.00118	0.0094	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.00111	0.00884	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.00108	0.0086	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	0.00105	0.00838	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	0.001	0.008	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	0.001	0.008	CbGpPWpGaD
Pamidronate—Histamine Phosphate—CYP3A4—prostate cancer	0.000932	0.0924	CrCbGaD
Pamidronate—FDPS—Metabolism—HAO1—prostate cancer	0.000914	0.00729	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	0.000852	0.0068	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	0.000817	0.00652	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	0.000786	0.00627	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	0.000759	0.00606	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—TST—prostate cancer	0.000745	0.00594	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ADI1—prostate cancer	0.000745	0.00594	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CBR1—prostate cancer	0.000745	0.00594	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PSAT1—prostate cancer	0.000745	0.00594	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CSAD—prostate cancer	0.000745	0.00594	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GRHL1—prostate cancer	0.000745	0.00594	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	0.000728	0.00581	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	0.000714	0.0057	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—PIK3CA—prostate cancer	0.000703	0.00561	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GRHPR—prostate cancer	0.000692	0.00553	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CKMT2—prostate cancer	0.000692	0.00553	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—UGT2B17—prostate cancer	0.000692	0.00553	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—UGT2B15—prostate cancer	0.000692	0.00553	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	0.000677	0.0054	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—MED12—prostate cancer	0.000666	0.00531	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTM3—prostate cancer	0.000651	0.0052	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—RFK—prostate cancer	0.000651	0.0052	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—AOX1—prostate cancer	0.000651	0.0052	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PGAM2—prostate cancer	0.000651	0.0052	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NAGLU—prostate cancer	0.000651	0.0052	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SULT2B1—prostate cancer	0.000651	0.0052	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—MBTPS1—prostate cancer	0.000651	0.0052	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	0.000636	0.00508	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—AMACR—prostate cancer	0.000617	0.00493	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP3A43—prostate cancer	0.000617	0.00493	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SRD5A2—prostate cancer	0.000617	0.00493	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—DEGS1—prostate cancer	0.000617	0.00493	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NAT1—prostate cancer	0.000617	0.00493	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	0.000607	0.00484	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	0.000603	0.00481	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HSD17B1—prostate cancer	0.000589	0.0047	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	0.000589	0.0047	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—AKT1—prostate cancer	0.000575	0.00459	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	0.000566	0.00452	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	0.000563	0.00449	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	0.000557	0.00445	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	0.000531	0.00424	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—B4GALT4—prostate cancer	0.000525	0.00419	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HPGD—prostate cancer	0.000525	0.00419	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—TNFRSF21—prostate cancer	0.000493	0.00394	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP7B1—prostate cancer	0.00048	0.00383	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—MTAP—prostate cancer	0.00048	0.00383	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.000469	0.00374	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SULT1E1—prostate cancer	0.000468	0.00373	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SRD5A1—prostate cancer	0.000468	0.00373	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.000454	0.00363	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.000447	0.00357	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HSD17B3—prostate cancer	0.000446	0.00356	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ACSL4—prostate cancer	0.000446	0.00356	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.000441	0.00352	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PHGDH—prostate cancer	0.000428	0.00341	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—UMPS—prostate cancer	0.000428	0.00341	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ARG2—prostate cancer	0.000428	0.00341	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.000426	0.0034	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—LDHB—prostate cancer	0.000419	0.00335	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP3A5—prostate cancer	0.000412	0.00329	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—UCP3—prostate cancer	0.000398	0.00317	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—TCN2—prostate cancer	0.000398	0.00317	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PDHA1—prostate cancer	0.000398	0.00317	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTA3—prostate cancer	0.000398	0.00317	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HSD3B1—prostate cancer	0.000379	0.00303	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SLC22A3—prostate cancer	0.000379	0.00303	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000368	0.00294	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—TBXAS1—prostate cancer	0.000364	0.0029	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTA4—prostate cancer	0.000364	0.0029	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000355	0.00284	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTA2—prostate cancer	0.000354	0.00283	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ABCG5—prostate cancer	0.00035	0.00279	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SULT1A1—prostate cancer	0.00035	0.00279	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTA1—prostate cancer	0.000342	0.00273	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NAT2—prostate cancer	0.000338	0.0027	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTO1—prostate cancer	0.000338	0.0027	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HSD3B2—prostate cancer	0.000338	0.0027	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000325	0.00259	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PLCB2—prostate cancer	0.000324	0.00259	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—LRP2—prostate cancer	0.000324	0.00259	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP2C18—prostate cancer	0.000324	0.00259	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—P4HB—prostate cancer	0.000318	0.00254	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SLC22A1—prostate cancer	0.000309	0.00247	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000306	0.00244	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SULT2A1—prostate cancer	0.000301	0.00241	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—MED12—prostate cancer	0.000296	0.00237	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GNG5—prostate cancer	0.000294	0.00235	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NCOA3—prostate cancer	0.000283	0.00226	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000278	0.00222	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HPGDS—prostate cancer	0.00027	0.00216	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP2C19—prostate cancer	0.000269	0.00214	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ACHE—prostate cancer	0.000262	0.00209	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTT1—prostate cancer	0.000262	0.00209	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP2A6—prostate cancer	0.000259	0.00207	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000258	0.00206	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—AKR1C3—prostate cancer	0.000252	0.00201	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PRKACB—prostate cancer	0.000251	0.002	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP17A1—prostate cancer	0.000248	0.00198	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000245	0.00195	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NCOA2—prostate cancer	0.000236	0.00189	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SLC5A5—prostate cancer	0.000226	0.0018	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP2E1—prostate cancer	0.00022	0.00176	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NQO1—prostate cancer	0.000218	0.00174	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—TH—prostate cancer	0.000215	0.00171	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000213	0.0017	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP3A4—prostate cancer	0.000212	0.0017	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000211	0.00169	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP1B1—prostate cancer	0.000209	0.00167	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GGT1—prostate cancer	0.000202	0.00161	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NCOA1—prostate cancer	0.000199	0.00159	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP19A1—prostate cancer	0.000196	0.00157	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—RXRA—prostate cancer	0.00019	0.00151	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.000184	0.00147	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—COMT—prostate cancer	0.000183	0.00146	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTP1—prostate cancer	0.000182	0.00145	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ITPR1—prostate cancer	0.000179	0.00143	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000176	0.0014	CbGpPWpGaD
Pamidronate—Thrombocytopenia—Capecitabine—prostate cancer	0.000175	0.000216	CcSEcCtD
Pamidronate—Syncope—Prednisone—prostate cancer	0.000175	0.000216	CcSEcCtD
Pamidronate—Tachycardia—Capecitabine—prostate cancer	0.000175	0.000216	CcSEcCtD
Pamidronate—Urinary tract disorder—Epirubicin—prostate cancer	0.000173	0.000214	CcSEcCtD
Pamidronate—Hyperhidrosis—Capecitabine—prostate cancer	0.000173	0.000214	CcSEcCtD
Pamidronate—Hypotension—Docetaxel—prostate cancer	0.000173	0.000213	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—prostate cancer	0.000173	0.000213	CcSEcCtD
Pamidronate—Connective tissue disorder—Epirubicin—prostate cancer	0.000173	0.000213	CcSEcCtD
Pamidronate—Urethral disorder—Epirubicin—prostate cancer	0.000172	0.000212	CcSEcCtD
Pamidronate—Loss of consciousness—Prednisone—prostate cancer	0.000172	0.000212	CcSEcCtD
Pamidronate—Anorexia—Capecitabine—prostate cancer	0.000171	0.000211	CcSEcCtD
Pamidronate—Nausea—Estradiol—prostate cancer	0.000171	0.000211	CcSEcCtD
Pamidronate—Vomiting—Mitoxantrone—prostate cancer	0.00017	0.00021	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—prostate cancer	0.00017	0.00021	CcSEcCtD
Pamidronate—Convulsion—Prednisone—prostate cancer	0.000169	0.000209	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—prostate cancer	0.000169	0.000209	CcSEcCtD
Pamidronate—FDPS—Metabolism—TYMS—prostate cancer	0.000169	0.00135	CbGpPWpGaD
Pamidronate—Hypertension—Prednisone—prostate cancer	0.000169	0.000208	CcSEcCtD
Pamidronate—Rash—Mitoxantrone—prostate cancer	0.000169	0.000208	CcSEcCtD
Pamidronate—Dermatitis—Mitoxantrone—prostate cancer	0.000169	0.000208	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000169	0.000208	CcSEcCtD
Pamidronate—Headache—Mitoxantrone—prostate cancer	0.000168	0.000207	CcSEcCtD
Pamidronate—Hypotension—Capecitabine—prostate cancer	0.000167	0.000207	CcSEcCtD
Pamidronate—Insomnia—Docetaxel—prostate cancer	0.000167	0.000207	CcSEcCtD
Pamidronate—FDPS—Metabolism—GSTM1—prostate cancer	0.000167	0.00133	CbGpPWpGaD
Pamidronate—Arthralgia—Prednisone—prostate cancer	0.000166	0.000205	CcSEcCtD
Pamidronate—Myalgia—Prednisone—prostate cancer	0.000166	0.000205	CcSEcCtD
Pamidronate—Paraesthesia—Docetaxel—prostate cancer	0.000166	0.000205	CcSEcCtD
Pamidronate—Anxiety—Prednisone—prostate cancer	0.000166	0.000205	CcSEcCtD
Pamidronate—Dyspnoea—Docetaxel—prostate cancer	0.000165	0.000204	CcSEcCtD
Pamidronate—Somnolence—Docetaxel—prostate cancer	0.000165	0.000203	CcSEcCtD
Pamidronate—Discomfort—Prednisone—prostate cancer	0.000164	0.000203	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—prostate cancer	0.000164	0.000203	CcSEcCtD
Pamidronate—Hypersensitivity—Etoposide—prostate cancer	0.000164	0.000202	CcSEcCtD
Pamidronate—FDPS—Metabolism—LPL—prostate cancer	0.000164	0.00131	CbGpPWpGaD
Pamidronate—Haemoglobin—Doxorubicin—prostate cancer	0.000163	0.000202	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000163	0.000201	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—prostate cancer	0.000163	0.000201	CcSEcCtD
Pamidronate—Flushing—Epirubicin—prostate cancer	0.000163	0.000201	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—prostate cancer	0.000163	0.000201	CcSEcCtD
Pamidronate—Dyspepsia—Docetaxel—prostate cancer	0.000163	0.000201	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—prostate cancer	0.000163	0.000201	CcSEcCtD
Pamidronate—Insomnia—Capecitabine—prostate cancer	0.000162	0.0002	CcSEcCtD
Pamidronate—Paraesthesia—Capecitabine—prostate cancer	0.000161	0.000199	CcSEcCtD
Pamidronate—Decreased appetite—Docetaxel—prostate cancer	0.000161	0.000198	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—prostate cancer	0.000161	0.000198	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00016	0.000197	CcSEcCtD
Pamidronate—Asthenia—Etoposide—prostate cancer	0.00016	0.000197	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—prostate cancer	0.00016	0.000197	CcSEcCtD
Pamidronate—Dyspnoea—Capecitabine—prostate cancer	0.00016	0.000197	CcSEcCtD
Pamidronate—Anaphylactic shock—Prednisone—prostate cancer	0.00016	0.000197	CcSEcCtD
Pamidronate—Oedema—Prednisone—prostate cancer	0.00016	0.000197	CcSEcCtD
Pamidronate—Fatigue—Docetaxel—prostate cancer	0.00016	0.000197	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—prostate cancer	0.000159	0.000197	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—prostate cancer	0.000159	0.000197	CcSEcCtD
Pamidronate—Nausea—Mitoxantrone—prostate cancer	0.000159	0.000196	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—prostate cancer	0.000159	0.000196	CcSEcCtD
Pamidronate—Infection—Prednisone—prostate cancer	0.000159	0.000196	CcSEcCtD
Pamidronate—Mediastinal disorder—Epirubicin—prostate cancer	0.000158	0.000195	CcSEcCtD
Pamidronate—FDPS—Metabolism—CYP1A1—prostate cancer	0.000158	0.00126	CbGpPWpGaD
Pamidronate—Pain—Docetaxel—prostate cancer	0.000158	0.000195	CcSEcCtD
Pamidronate—Constipation—Docetaxel—prostate cancer	0.000158	0.000195	CcSEcCtD
Pamidronate—Dyspepsia—Capecitabine—prostate cancer	0.000158	0.000195	CcSEcCtD
Pamidronate—Chills—Epirubicin—prostate cancer	0.000158	0.000195	CcSEcCtD
Pamidronate—Pruritus—Etoposide—prostate cancer	0.000158	0.000194	CcSEcCtD
Pamidronate—Shock—Prednisone—prostate cancer	0.000157	0.000194	CcSEcCtD
Pamidronate—FDPS—Metabolism—ERCC2—prostate cancer	0.000157	0.00125	CbGpPWpGaD
Pamidronate—Nervous system disorder—Prednisone—prostate cancer	0.000157	0.000193	CcSEcCtD
Pamidronate—Tachycardia—Prednisone—prostate cancer	0.000156	0.000192	CcSEcCtD
Pamidronate—Decreased appetite—Capecitabine—prostate cancer	0.000156	0.000192	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—prostate cancer	0.000155	0.000192	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000155	0.000191	CcSEcCtD
Pamidronate—Fatigue—Capecitabine—prostate cancer	0.000154	0.000191	CcSEcCtD
Pamidronate—Hyperhidrosis—Prednisone—prostate cancer	0.000154	0.00019	CcSEcCtD
Pamidronate—Pain—Capecitabine—prostate cancer	0.000153	0.000189	CcSEcCtD
Pamidronate—Constipation—Capecitabine—prostate cancer	0.000153	0.000189	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—prostate cancer	0.000153	0.000189	CcSEcCtD
Pamidronate—Erythema—Epirubicin—prostate cancer	0.000153	0.000189	CcSEcCtD
Pamidronate—Feeling abnormal—Docetaxel—prostate cancer	0.000152	0.000188	CcSEcCtD
Pamidronate—Diarrhoea—Etoposide—prostate cancer	0.000152	0.000188	CcSEcCtD
Pamidronate—Anorexia—Prednisone—prostate cancer	0.000152	0.000188	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—prostate cancer	0.000152	0.000187	CcSEcCtD
Pamidronate—Gastrointestinal pain—Docetaxel—prostate cancer	0.000151	0.000187	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—prostate cancer	0.000151	0.000186	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—prostate cancer	0.000151	0.000186	CcSEcCtD
Pamidronate—Tension—Epirubicin—prostate cancer	0.00015	0.000185	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—prostate cancer	0.00015	0.000185	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—prostate cancer	0.000149	0.000183	CcSEcCtD
Pamidronate—Back pain—Epirubicin—prostate cancer	0.000148	0.000183	CcSEcCtD
Pamidronate—Feeling abnormal—Capecitabine—prostate cancer	0.000148	0.000182	CcSEcCtD
Pamidronate—FDPS—Metabolism—MTHFR—prostate cancer	0.000148	0.00118	CbGpPWpGaD
Pamidronate—Angiopathy—Doxorubicin—prostate cancer	0.000147	0.000182	CcSEcCtD
Pamidronate—Dizziness—Etoposide—prostate cancer	0.000147	0.000182	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—prostate cancer	0.000147	0.000181	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—prostate cancer	0.000147	0.000181	CcSEcCtD
Pamidronate—Gastrointestinal pain—Capecitabine—prostate cancer	0.000147	0.000181	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—prostate cancer	0.000147	0.000181	CcSEcCtD
Pamidronate—Abdominal pain—Docetaxel—prostate cancer	0.000146	0.000181	CcSEcCtD
Pamidronate—Body temperature increased—Docetaxel—prostate cancer	0.000146	0.000181	CcSEcCtD
Pamidronate—Chills—Doxorubicin—prostate cancer	0.000146	0.00018	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000145	0.000179	CcSEcCtD
Pamidronate—FDPS—Metabolism—PPARA—prostate cancer	0.000145	0.00116	CbGpPWpGaD
Pamidronate—Insomnia—Prednisone—prostate cancer	0.000144	0.000178	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—prostate cancer	0.000144	0.000177	CcSEcCtD
Pamidronate—Paraesthesia—Prednisone—prostate cancer	0.000143	0.000177	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—prostate cancer	0.000142	0.000175	CcSEcCtD
Pamidronate—Abdominal pain—Capecitabine—prostate cancer	0.000142	0.000175	CcSEcCtD
Pamidronate—Body temperature increased—Capecitabine—prostate cancer	0.000142	0.000175	CcSEcCtD
Pamidronate—Vomiting—Etoposide—prostate cancer	0.000142	0.000175	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—prostate cancer	0.000142	0.000175	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—prostate cancer	0.000142	0.000175	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—prostate cancer	0.000141	0.000174	CcSEcCtD
Pamidronate—Agitation—Epirubicin—prostate cancer	0.000141	0.000173	CcSEcCtD
Pamidronate—Dyspepsia—Prednisone—prostate cancer	0.00014	0.000173	CcSEcCtD
Pamidronate—Rash—Etoposide—prostate cancer	0.00014	0.000173	CcSEcCtD
Pamidronate—Dermatitis—Etoposide—prostate cancer	0.00014	0.000173	CcSEcCtD
Pamidronate—Headache—Etoposide—prostate cancer	0.000139	0.000172	CcSEcCtD
Pamidronate—Tension—Doxorubicin—prostate cancer	0.000139	0.000171	CcSEcCtD
Pamidronate—Decreased appetite—Prednisone—prostate cancer	0.000139	0.000171	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—prostate cancer	0.000139	0.000171	CcSEcCtD
Pamidronate—Malaise—Epirubicin—prostate cancer	0.000138	0.00017	CcSEcCtD
Pamidronate—Fatigue—Prednisone—prostate cancer	0.000138	0.00017	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—prostate cancer	0.000137	0.00017	CcSEcCtD
Pamidronate—Syncope—Epirubicin—prostate cancer	0.000137	0.000169	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—prostate cancer	0.000137	0.000169	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—prostate cancer	0.000137	0.000169	CcSEcCtD
Pamidronate—Constipation—Prednisone—prostate cancer	0.000136	0.000168	CcSEcCtD
Pamidronate—Hypersensitivity—Docetaxel—prostate cancer	0.000136	0.000168	CcSEcCtD
Pamidronate—FDPS—Metabolism—CAV1—prostate cancer	0.000136	0.00109	CbGpPWpGaD
Pamidronate—Muscle spasms—Doxorubicin—prostate cancer	0.000136	0.000168	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—prostate cancer	0.000134	0.000166	CcSEcCtD
Pamidronate—Cough—Epirubicin—prostate cancer	0.000133	0.000165	CcSEcCtD
Pamidronate—Asthenia—Docetaxel—prostate cancer	0.000133	0.000164	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—prostate cancer	0.000133	0.000164	CcSEcCtD
Pamidronate—Nausea—Etoposide—prostate cancer	0.000132	0.000163	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—prostate cancer	0.000132	0.000163	CcSEcCtD
Pamidronate—Hypersensitivity—Capecitabine—prostate cancer	0.000132	0.000163	CcSEcCtD
Pamidronate—Feeling abnormal—Prednisone—prostate cancer	0.000132	0.000162	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—prostate cancer	0.000131	0.000162	CcSEcCtD
Pamidronate—Pruritus—Docetaxel—prostate cancer	0.000131	0.000162	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—prostate cancer	0.000131	0.000161	CcSEcCtD
Pamidronate—Gastrointestinal pain—Prednisone—prostate cancer	0.000131	0.000161	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—prostate cancer	0.00013	0.000161	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—prostate cancer	0.00013	0.000161	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.00013	0.00104	CbGpPWpGaD
Pamidronate—Agitation—Doxorubicin—prostate cancer	0.00013	0.00016	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—prostate cancer	0.00013	0.00016	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—prostate cancer	0.000129	0.000159	CcSEcCtD
Pamidronate—Asthenia—Capecitabine—prostate cancer	0.000129	0.000159	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—prostate cancer	0.000128	0.000157	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—prostate cancer	0.000127	0.000157	CcSEcCtD
Pamidronate—Pruritus—Capecitabine—prostate cancer	0.000127	0.000156	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—prostate cancer	0.000127	0.000156	CcSEcCtD
Pamidronate—Diarrhoea—Docetaxel—prostate cancer	0.000127	0.000156	CcSEcCtD
Pamidronate—Body temperature increased—Prednisone—prostate cancer	0.000126	0.000156	CcSEcCtD
Pamidronate—Abdominal pain—Prednisone—prostate cancer	0.000126	0.000156	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—prostate cancer	0.000126	0.000155	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—prostate cancer	0.000125	0.000154	CcSEcCtD
Pamidronate—Oedema—Epirubicin—prostate cancer	0.000125	0.000154	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—prostate cancer	0.000124	0.000153	CcSEcCtD
Pamidronate—Infection—Epirubicin—prostate cancer	0.000124	0.000153	CcSEcCtD
Pamidronate—FDPS—Metabolism—PIK3CG—prostate cancer	0.000124	0.00099	CbGpPWpGaD
Pamidronate—Cough—Doxorubicin—prostate cancer	0.000123	0.000152	CcSEcCtD
Pamidronate—Shock—Epirubicin—prostate cancer	0.000123	0.000152	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—prostate cancer	0.000123	0.000151	CcSEcCtD
Pamidronate—Diarrhoea—Capecitabine—prostate cancer	0.000123	0.000151	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—prostate cancer	0.000122	0.000151	CcSEcCtD
Pamidronate—Dizziness—Docetaxel—prostate cancer	0.000122	0.000151	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—prostate cancer	0.000122	0.000151	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—prostate cancer	0.000122	0.000151	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—prostate cancer	0.000122	0.00015	CcSEcCtD
Pamidronate—Hyperhidrosis—Epirubicin—prostate cancer	0.000121	0.000149	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—prostate cancer	0.00012	0.000149	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—prostate cancer	0.00012	0.000149	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—prostate cancer	0.00012	0.000148	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—prostate cancer	0.000119	0.000147	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—prostate cancer	0.000119	0.000147	CcSEcCtD
Pamidronate—Dizziness—Capecitabine—prostate cancer	0.000118	0.000146	CcSEcCtD
Pamidronate—Vomiting—Docetaxel—prostate cancer	0.000118	0.000145	CcSEcCtD
Pamidronate—Hypersensitivity—Prednisone—prostate cancer	0.000118	0.000145	CcSEcCtD
Pamidronate—FDPS—Metabolism—INS—prostate cancer	0.000117	0.000937	CbGpPWpGaD
Pamidronate—Rash—Docetaxel—prostate cancer	0.000117	0.000144	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—prostate cancer	0.000117	0.000144	CcSEcCtD
Pamidronate—Dermatitis—Docetaxel—prostate cancer	0.000117	0.000144	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—prostate cancer	0.000116	0.000144	CcSEcCtD
Pamidronate—Headache—Docetaxel—prostate cancer	0.000116	0.000143	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—prostate cancer	0.000115	0.000143	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—prostate cancer	0.000115	0.000143	CcSEcCtD
Pamidronate—FDPS—Metabolism—CREBBP—prostate cancer	0.000115	0.000918	CbGpPWpGaD
Pamidronate—Infection—Doxorubicin—prostate cancer	0.000115	0.000142	CcSEcCtD
Pamidronate—Asthenia—Prednisone—prostate cancer	0.000115	0.000141	CcSEcCtD
Pamidronate—Vomiting—Capecitabine—prostate cancer	0.000114	0.000141	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000114	0.00014	CcSEcCtD
Pamidronate—Shock—Doxorubicin—prostate cancer	0.000114	0.00014	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—prostate cancer	0.000113	0.00014	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—prostate cancer	0.000113	0.00014	CcSEcCtD
Pamidronate—Rash—Capecitabine—prostate cancer	0.000113	0.000139	CcSEcCtD
Pamidronate—Pruritus—Prednisone—prostate cancer	0.000113	0.000139	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—prostate cancer	0.000113	0.000139	CcSEcCtD
Pamidronate—Dermatitis—Capecitabine—prostate cancer	0.000113	0.000139	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—prostate cancer	0.000113	0.000139	CcSEcCtD
Pamidronate—Headache—Capecitabine—prostate cancer	0.000112	0.000138	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—prostate cancer	0.000112	0.000138	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—prostate cancer	0.000112	0.000138	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—prostate cancer	0.000111	0.000137	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—prostate cancer	0.000111	0.000137	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—prostate cancer	0.00011	0.000136	CcSEcCtD
Pamidronate—Nausea—Docetaxel—prostate cancer	0.00011	0.000136	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—prostate cancer	0.00011	0.000136	CcSEcCtD
Pamidronate—Diarrhoea—Prednisone—prostate cancer	0.000109	0.000135	CcSEcCtD
Pamidronate—FDPS—Metabolism—PIK3CD—prostate cancer	0.000109	0.00087	CbGpPWpGaD
Pamidronate—Decreased appetite—Epirubicin—prostate cancer	0.000109	0.000134	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—prostate cancer	0.000108	0.000133	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000108	0.000133	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—prostate cancer	0.000108	0.000133	CcSEcCtD
Pamidronate—Pain—Epirubicin—prostate cancer	0.000107	0.000132	CcSEcCtD
Pamidronate—Constipation—Epirubicin—prostate cancer	0.000107	0.000132	CcSEcCtD
Pamidronate—Nausea—Capecitabine—prostate cancer	0.000106	0.000131	CcSEcCtD
Pamidronate—Dizziness—Prednisone—prostate cancer	0.000106	0.00013	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000105	0.00013	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—prostate cancer	0.000104	0.000129	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—prostate cancer	0.000104	0.000128	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—prostate cancer	0.000103	0.000127	CcSEcCtD
Pamidronate—FDPS—Metabolism—NOS3—prostate cancer	0.000103	0.000822	CbGpPWpGaD
Pamidronate—Feeling abnormal—Epirubicin—prostate cancer	0.000103	0.000127	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—prostate cancer	0.000103	0.000127	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—prostate cancer	0.000102	0.000126	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—prostate cancer	0.000102	0.000125	CcSEcCtD
Pamidronate—Vomiting—Prednisone—prostate cancer	0.000101	0.000125	CcSEcCtD
Pamidronate—Rash—Prednisone—prostate cancer	0.000101	0.000124	CcSEcCtD
Pamidronate—Dermatitis—Prednisone—prostate cancer	0.000101	0.000124	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—prostate cancer	0.0001	0.000124	CcSEcCtD
Pamidronate—Headache—Prednisone—prostate cancer	0.0001	0.000123	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.97e-05	0.000123	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—prostate cancer	9.96e-05	0.000123	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—prostate cancer	9.88e-05	0.000122	CcSEcCtD
Pamidronate—Pain—Doxorubicin—prostate cancer	9.88e-05	0.000122	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—prostate cancer	9.87e-05	0.000122	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—prostate cancer	9.87e-05	0.000122	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—prostate cancer	9.52e-05	0.000117	CcSEcCtD
Pamidronate—FDPS—Metabolism—PIK3CB—prostate cancer	9.5e-05	0.000758	CbGpPWpGaD
Pamidronate—Nausea—Prednisone—prostate cancer	9.48e-05	0.000117	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—prostate cancer	9.44e-05	0.000117	CcSEcCtD
Pamidronate—FDPS—Metabolism—PTGS2—prostate cancer	9.41e-05	0.000751	CbGpPWpGaD
Pamidronate—Hypersensitivity—Epirubicin—prostate cancer	9.2e-05	0.000113	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—prostate cancer	9.13e-05	0.000113	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—prostate cancer	9.13e-05	0.000113	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—prostate cancer	8.96e-05	0.00011	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—prostate cancer	8.83e-05	0.000109	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—prostate cancer	8.54e-05	0.000105	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—prostate cancer	8.51e-05	0.000105	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—prostate cancer	8.29e-05	0.000102	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—prostate cancer	8.25e-05	0.000102	CcSEcCtD
Pamidronate—FDPS—Metabolism—PTEN—prostate cancer	8.21e-05	0.000655	CbGpPWpGaD
Pamidronate—Pruritus—Doxorubicin—prostate cancer	8.17e-05	0.000101	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—prostate cancer	7.94e-05	9.79e-05	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—prostate cancer	7.9e-05	9.75e-05	CcSEcCtD
Pamidronate—Rash—Epirubicin—prostate cancer	7.87e-05	9.71e-05	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—prostate cancer	7.86e-05	9.7e-05	CcSEcCtD
Pamidronate—FDPS—Metabolism—EP300—prostate cancer	7.83e-05	0.000625	CbGpPWpGaD
Pamidronate—Headache—Epirubicin—prostate cancer	7.82e-05	9.65e-05	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—prostate cancer	7.64e-05	9.42e-05	CcSEcCtD
Pamidronate—Nausea—Epirubicin—prostate cancer	7.41e-05	9.15e-05	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—prostate cancer	7.34e-05	9.06e-05	CcSEcCtD
Pamidronate—Rash—Doxorubicin—prostate cancer	7.28e-05	8.99e-05	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—prostate cancer	7.28e-05	8.98e-05	CcSEcCtD
Pamidronate—Headache—Doxorubicin—prostate cancer	7.24e-05	8.93e-05	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—prostate cancer	6.86e-05	8.46e-05	CcSEcCtD
Pamidronate—FDPS—Metabolism—PIK3CA—prostate cancer	5.79e-05	0.000462	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—AKT1—prostate cancer	4.73e-05	0.000378	CbGpPWpGaD
